CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,296 | -52.9% | 29,956 | -29.5% | 0.00% | – |
| Q3 2022 | $7,000 | – | 42,504 | +2078.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,951 | -90.9% | 0.00% | – |
| Q1 2022 | $11,000 | -54.2% | 21,379 | -44.6% | 0.00% | – |
| Q4 2021 | $24,000 | +100.0% | 38,580 | +260.2% | 0.00% | – |
| Q3 2021 | $12,000 | -63.6% | 10,712 | -39.9% | 0.00% | – |
| Q2 2021 | $33,000 | -15.4% | 17,825 | -9.4% | 0.00% | – |
| Q1 2021 | $39,000 | +875.0% | 19,668 | +467.9% | 0.00% | – |
| Q4 2020 | $4,000 | -42.9% | 3,463 | -13.0% | 0.00% | – |
| Q3 2020 | $7,000 | -99.5% | 3,979 | -97.7% | 0.00% | -100.0% |
| Q2 2020 | $1,461,000 | +582.7% | 174,082 | +327.2% | 0.00% | – |
| Q1 2020 | $214,000 | -55.0% | 40,748 | -53.2% | 0.00% | – |
| Q4 2019 | $476,000 | +91.9% | 87,142 | +70.8% | 0.00% | – |
| Q3 2019 | $248,000 | +153.1% | 51,027 | +261.9% | 0.00% | – |
| Q2 2019 | $98,000 | +10.1% | 14,101 | +10.8% | 0.00% | – |
| Q1 2019 | $89,000 | +56.1% | 12,725 | +31.5% | 0.00% | – |
| Q4 2018 | $57,000 | +72.7% | 9,679 | +126.7% | 0.00% | – |
| Q3 2018 | $33,000 | +50.0% | 4,270 | -0.6% | 0.00% | – |
| Q2 2018 | $22,000 | +37.5% | 4,295 | +65.2% | 0.00% | – |
| Q1 2018 | $16,000 | +128.6% | 2,600 | +160.0% | 0.00% | – |
| Q4 2017 | $7,000 | -69.6% | 1,000 | -69.1% | 0.00% | – |
| Q3 2017 | $23,000 | +91.7% | 3,233 | +68.5% | 0.00% | – |
| Q2 2017 | $12,000 | +33.3% | 1,919 | +66.9% | 0.00% | – |
| Q1 2017 | $9,000 | +12.5% | 1,150 | +15.0% | 0.00% | – |
| Q4 2016 | $8,000 | -46.7% | 1,000 | -54.7% | 0.00% | – |
| Q3 2016 | $15,000 | +114.3% | 2,206 | -0.7% | 0.00% | – |
| Q2 2016 | $7,000 | +40.0% | 2,222 | -22.2% | 0.00% | – |
| Q1 2016 | $5,000 | -16.7% | 2,856 | -16.3% | 0.00% | – |
| Q4 2015 | $6,000 | -14.3% | 3,411 | -14.7% | 0.00% | – |
| Q3 2015 | $7,000 | +16.7% | 4,001 | +101.2% | 0.00% | – |
| Q2 2015 | $6,000 | – | 1,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |